{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:45:27Z","timestamp":1792100727594,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.xphs.2026.104526","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:09:38Z","timestamp":1791414578000},"page":"104526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation for the cause of vial breakage during frozen storage of nucleic acid drug solution and the effect of the internal coating on the vial strain"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4968-2992","authenticated-orcid":false,"given":"Hiroaki","family":"Taga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104526_bib0001","article-title":"Comprehensive review of adverse reactions and toxicology in ASO-based therapies for Duchenne muscular dystrophy: from FDA-approved drugs to peptide-conjugated ASO","volume":"7","author":"Sabrina","year":"2024","journal-title":"Curr Res Toxicol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104526_bib0002","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/molecules22040563","article-title":"Antisense oligonucleotide-based therapy for neuromuscular disease","volume":"22","author":"Sardone","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.xphs.2026.104526_bib0003","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.3390\/ijms24044019","article-title":"Development of novel siRNA therapeutics: a review with a focus on inclisiran for the treatment of hypercholesterolemia","volume":"24","author":"Ebenezer","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104526_bib0004","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.123.067957","article-title":"Established and emerging nucleic acid therapies for familial hypercholesterolemia","volume":"150","author":"Damase","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.xphs.2026.104526_bib0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/vaccines9020147","article-title":"SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond","volume":"9","author":"Bettini","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.xphs.2026.104526_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109934","article-title":"An insight overview on COVID-19 mRNA vaccines: advantageous, pharmacology, mechanism of action, and prospective considerations","volume":"117","author":"Mirtaleb","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104526_bib0007","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10238-024-01463-4","article-title":"Advances in nucleic acid therapeutics: structures, delivery systems, and future perspectives in cancer treatment","volume":"24","author":"Zhang","year":"2024","journal-title":"Clin Exp Med"},{"issue":"1","key":"10.1016\/j.xphs.2026.104526_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102440","article-title":"Nucleic acid therapeutics: past, present, and future","volume":"36","author":"Naeem","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"10.1016\/j.xphs.2026.104526_bib0009","first-page":"32","article-title":"Large-scale freezing of biologics: a practitioner\u2019s review, part one: fundamental aspects","volume":"7","author":"Singh","year":"2009","journal-title":"BioProcess Int"},{"issue":"1","key":"10.1016\/j.xphs.2026.104526_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.xphs.2019.10.062","article-title":"Freezing of biologicals revisited: scale, stability, excipients, and degradation stresses","volume":"109","author":"Authelin","year":"2020","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104526_bib0011","first-page":"441","article-title":"Mechanistic studies of glass vial breakage for frozen formulations. I. Vial breakage caused by crystallizable excipient mannitol","volume":"61","author":"Jiang","year":"2007","journal-title":"PDA J Pharm Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104526_bib0012","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5731\/pdajpst.2012.00861","article-title":"Investigation of freeze\/thaw-related quality attributes of a liquid biopharmaceutical formulation: the role of saccharide excipients","volume":"66","author":"Zhou","year":"2012","journal-title":"PDA J Pharm Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104526_bib0013","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10973-006-7663-6","article-title":"Mechanism of glass ampoule breakage prevention during the freeze-drying process of sodium thiopental lyophilization products on addition of sodium chloride","volume":"85","author":"Ito","year":"2006","journal-title":"J Therm Anal Calorim"},{"issue":"7","key":"10.1016\/j.xphs.2026.104526_bib0014","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/jps.20854","article-title":"Vial breakage during freeze-drying: crystallization of sodium chloride in sodium chloride-sucrose frozen aqueous solutions","volume":"96","author":"Milton","year":"2007","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104526_bib0015","first-page":"452","article-title":"Mechanistic studies of glass vial breakage for frozen formulations. II. Vial breakage caused by amorphous protein formulations","volume":"61","author":"Jiang","year":"2007","journal-title":"PDA J Pharm Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104526_bib0016","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5731\/pdajpst.2017.008276","article-title":"Failure of glass tubing vials during lyophilization","volume":"73","author":"Machak","year":"2019","journal-title":"PDA J Pharm Sci Technol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104526_bib0017","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.xphs.2022.11.007","article-title":"Vial breakage in lyophilization-case studies from commercial manufacturing and laboratory studies","volume":"112","author":"Sahni","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104526_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118510","article-title":"Quality attributes and evaluation of pharmaceutical glass containers for parenterals","volume":"568","author":"Srinivasan","year":"2019","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2026.104526_bib0019","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.xphs.2023.12.010","article-title":"Freeze drying and vial breakage: misconceptions, root causes and mitigation strategies for the pharmaceutical industry","volume":"113","author":"Jin","year":"2024","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104526_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107011","article-title":"Impact of vial quality on interactions, particle formation, container closure integrity, and gas permeability for frozen drug product storage","volume":"206","author":"Henle","year":"2025","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104526_bib0034","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5731\/pdajpst.2014.00998","article-title":"A new glass option for parenteral packaging","volume":"68","author":"Schaut","year":"2014","journal-title":"PDA J Pharm Sci Technol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104526_bib0021","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1208\/s12249-014-0167-y","article-title":"Glass delamination: a comparison of the inner surface performance of vials and pre-filled syringes","volume":"15","author":"Zhao","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.xphs.2026.104526_bib0022","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1021\/acsaenm.3c00584","article-title":"Silicon oxynitride coatings are very promising for inert and durable pharmaceutical glass vials","volume":"1","author":"Topka","year":"2023","journal-title":"ACS Appl Eng Mater"},{"issue":"2","key":"10.1016\/j.xphs.2026.104526_bib0023","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejpb.2013.06.007","article-title":"Investigating factors leading to fogging of glass vials in lyophilized drug products","volume":"85","author":"Abdul-Fattah","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104526_bib0024","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.xphs.2019.08.024","article-title":"Method to predict glass vial fogging in lyophilized drug products","volume":"109","author":"Langer","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104526_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107040","article-title":"Impact of surface energy and surface tension on vial fogging within lyophilized drug products","volume":"207","author":"Shu","year":"2025","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104526_bib0026","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11095-018-2421-6","article-title":"Impact of vial washing and depyrogenation on surface properties and delamination risk of glass vials","volume":"35","author":"Ditter","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104526_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijthermalsci.2022.108090","article-title":"Formation mechanism of freezing interface strain and effect of different factors on freezing interface strain","volume":"185","author":"Jin","year":"2023","journal-title":"Int J Therm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104526_bib0027","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5731\/pdajpst.2013.00925","article-title":"Novel mechanism of glass delamination in Type 1A borosilicate vials containing frozen protein formulations","volume":"67","author":"Jiang","year":"2013","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.xphs.2026.104526_bib0028","doi-asserted-by":"crossref","first-page":"8369","DOI":"10.1038\/srep08369","article-title":"A simple method for tuning the glass transition process in inorganic phosphate glasses","volume":"5","author":"Fulchiron","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2026.104526_bib0030","series-title":"Macromolecular Physics Vol. 1 Crystal Structure, Morphology, Defects","author":"Wunderlich","year":"1976"},{"key":"10.1016\/j.xphs.2026.104526_bib0031","series-title":"Handbook of Polymer Crystallization","author":"Piorkowska","year":"2013"},{"issue":"5","key":"10.1016\/j.xphs.2026.104526_bib0035","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/nar\/gkx056","article-title":"Managing the sequence-specificity of antisense oligonucleotides in drug discovery","volume":"45","author":"Hagedorn","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xphs.2026.104526_bib0036","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1038\/s41467-023-43714-0","article-title":"Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry","volume":"14","author":"Terada","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.xphs.2026.104526_bib0037","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1021\/acs.molpharmaceut.3c00764","article-title":"Solid-state NMR spectroscopy to probe state and phase transitions in frozen solutions","volume":"20","author":"Du","year":"2023","journal-title":"Mol Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2026.104526_bib0032","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jps.24284","article-title":"Measurement of shrinkage and cracking in lyophilized amorphous cakes. Part I: final-product assessment","volume":"104","author":"Ullrich","year":"2015","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104526_bib0033","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/jps.24441","article-title":"Measurement of shrinkage and cracking in lyophilized amorphous cakes part 3: hydrophobic vials and the question of adhesion","volume":"104","author":"Ullrich","year":"2015","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492600376X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492600376X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:07:52Z","timestamp":1792098472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492600376X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S002235492600376X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104526","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation for the cause of vial breakage during frozen storage of nucleic acid drug solution and the effect of the internal coating on the vial strain","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104526"}}